Redsense Medical AB

Research Redsense Medical AB (REDS) on Bullrun: market cap SEK 65.62M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is SEK 65.62M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025SEK 24.02M-SEK 7.17M-SEK 8.02M64.8%-1.62SEK 7.36Mn/aSEK 34.28M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-14SEK 65.62Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About Redsense Medical AB

Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2000 and is headquartered in Halmstad, Sweden.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Redsense Medical AB's market cap?

Redsense Medical AB's market capitalization is SEK 65.62M.

What does Redsense Medical AB do?

Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2000 and is headquartered in Halmstad, Sweden.